EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April) suggests that many of the symptoms connected to post-COVID syndrome (PCC, also known as long COVID) could be linked to the effect of the virus on...
Tag: <span>SARS-CoV-2</span>
Post
Newly developed inhaled vaccine delivers broad protection against SARS-CoV-2, variants
by McMaster University Michael D’Agostino demonstrates how a nebulizer would deliver an inhaled vaccine. A new study has found the McMaster-developed vaccine to be effective against variants of concern. Credit: McMaster University Scientists at McMaster University who have developed an inhaled form of COVID vaccine have confirmed it can provide broad, long-lasting protection against the...
Post
New antiviral drug combination is highly effective against SARS-CoV-2, study finds
by Perelman School of Medicine at the University of Pennsylvania Colorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIH/NIAID Researchers have identified a powerful combination of antivirals to...
Post
Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2
By Susha Cheriyedath, M.Sc. Feb 4 2022 Reviewed by Aimee Molineux In a recent paper posted to the bioRxiv* preprint server, researchers showed that 425 nm blue light can inactivate all major severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) variants. They demonstrated that at twice-daily dosing, 425 nm light inhibited Beta and Delta variant replication in...
Post
Researchers identify immunological markers for SARS-CoV-2 reinfection
AMERICAN SOCIETY FOR MICROBIOLOGY Highlights: Tracking new hotspots of SARS-CoV-2 will become more important as the virus evolves and becomes endemic. New variants may be more contagious than previous ones—and escape vaccines. Serum biomarkers, identified in rhesus macaques, can differentiate between primary infection and reinfection. A tool utilizing these biomarkers may help identify surges in...
Post
‘Superpower’ nano bubbles could treat, prevent current and future strains of SARS-CoV-2
NORTHWESTERN UNIVERSITY Drug can be delivered as nasal spray Acts as decoy to capture virus before it enters cell ‘It’s urgent to identify novel therapeutics’ EvACE2 arises naturally in COVID-19 patients as part of the anti-viral response CHICAGO — Scientists at Northwestern Medicine and The University of Texas MD Anderson Cancer Center have identified natural nano-bubbles containing the...
Post
T cells from common colds cross-protect against infection with SARS-CoV-2
by Imperial College London A colorized scanning electron micrograph of the SARS-CoV-2 virus. Credit: NIAID A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T cells. While previous studies have shown that T cells induced by other coronaviruses can recognize SARS-CoV-2, the...
Post
A new medication uses protein against SARS-CoV-2
by Technical University Munich Prof. Dr. med. Ulrike Protzer (r), head of the Institute for Virology at the Technical University of Munich and Director at the Helmholtz Munich, with an employee at the PCR analyzer in the Institute for Virology at the TUM university hospital Klinikum rechts der Isar. Credit: Astrid Eckert / TUM Vaccines against...
Post
Rapid PCR tests at the touch of a button
by Rahel Künzler, ETH Zurich Philippe Bechtold (left) and Michele Gregorini are much less often in the laboratory since they have founded their own company. Credit: Alessandro Della Bella/ETH Zurich ETH researchers Michele Gregorini and Philippe Bechtold have developed a PCR testing device that can easily be used outside the lab—and that takes less than 30...
Post
Study reports a novel broad-spectrum antiviral drug class with activity against SARS-CoV-2
by Georgia State University Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID The COVID-19 pandemic and resurgence of infections by other respiratory RNA viruses such as respiratory syncytial virus (RSV) in children has caused an...